Acceptance Factors of Pneumococcal Vaccination among Adult Population: A Systematic Review

@#Pneumococcal disease causes considerable morbidity and mortality, including among adults. Adult pneumococcal vaccines help to prevent these burdens, yet, they are underutilized. Our objective is to systematically collect and summarize the available evidence on the potential factors that lead to pneumococcal vaccination acceptance among of adult community.

Acute Disseminated Encephalomyelitis Following Pneumococcal Vaccination

No abstract available.

Puesta al día en vacunación antineumocócica en adultos / Update on pneumococcal vaccination in adults

La enfermedad invasiva por Streptococcus pneumoniae constituye una importante causa de morbilidad y mortalidad, y es la primera causa de muerte prevenible mediante vacunación en el mundo, no solo en niños sino en todas las edades. Tanto la vacuna polisacárida como la vacuna conjugada antineumocócicas han demostrado reducción de las tasas de enfermedad invasiva en adultos. En los últimos años, a la luz de nueva evidencia disponible, los esquemas de vacunación antineumocócica para esta población han sufrido modificaciones. Este documento ofrece una actualización sobre las recomendaciones de vacunación a través de los fundamentos que han llevado a dicho cambio. (AU)

The Streptococcus pneumoniae invasive disease is a major cause of morbidity and mortality, being the leading cause of vaccine-preventable death in the world, not only in children but in all ages. Both the polysaccharide vaccine and pneumococcal conjugate vaccine have shown reduced rates of invasive disease in adults. In recent years, in light of new evidence available, schedules of pneumococcal vaccination for this population have changed. This document provides an update on vaccine recommendations through the rational that have led to this change. (AU)

Infection Control in Office-based Practices

Infection control in the setting of the office based clinic, involves the early detection of disease; disease prevention through vaccination as in influenza and pneumococcal vaccinations; and through screening for asymptomatic disease as in tuberculosis. Family physicians play an important role in these aspects within the community. Although influenza vaccination is effective, the take up rate of vaccination locally is low. Annual vaccination with the current vaccines are strongly recommended in high risk populations such as the elderly, the immunocompromised and, those with co-morbidities. The inactivated trivalent vaccine is the most commonly used. Latent Tuberculosis (TB) Infection is asymptomatic and often goes undetected. Prevention of progression to overt TB can be achieved by identifying high risk persons and the early detection by either the tuberculin skin test or interferon gamma release assays (IGRAs). Invasive pneumococcal disease can lead to significant morbidity and mortality in the young and elderly. In the preventive control of this disease, there are two types of pneumococcal vaccines currently available – the polysaccharide vaccine and the conjugate vaccine. Recommendations for the two different vaccines are in accordance with different at risk populations.

Outpatient-Based Pneumococcal Vaccine Campaign and Survey of Perceptions about Pneumococcal Vaccination in Patients and Doctors

PURPOSE: Despite the ready availability of pneumococcal vaccine, vaccination rates are quite low in South Korea. This study was designed to assess perceptions and awareness about pneumococcal vaccines among subjects at risk and find strategies to increases vaccine coverage rates. MATERIALS AND METHODS: A cross sectional, community-based survey was conducted to assess perceptions about the pneumococcal vaccine at a local public health center. In a tertiary hospital, an outpatient-based pneumococcal vaccine campaign was carried out for the elderly and individuals with chronic co-morbidities from May to July of 2007. RESULTS: Based on the survey, only 7.6% were ever informed about pneumococcal vaccination. The coverage rates of the pneumococcal vaccine before and after the hospital campaign showed an increased annual rate from 3.39% to 5.91%. The most common reason for vaccination was "doctor's advice" (53.3%). As for the reasons for not receiving vaccination, about 75% of high risk patients were not aware of the pneumococcal vaccine, which was the most important barrier to vaccination. Negative clinician's attitude was the second most common cause of non-vaccination. CONCLUSION: Annual outpatient-based campaigns early in the influenza season may improve pneumococcal vaccine coverage rates. Doctor's advice was the most important encouraging factor for vaccination.